Author:
Prakash Tara C,Enkemann Steven
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. Clinical pharmacokinetic and pharmacodynamic overview of nilotinib, a selective tyrosine kinase inhibitor;Tian X;J Clin Pharmacol,2018
2. Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review;Kumar V;Mol Cell Biochem,2022
3. Defining and managing imatinib resistance;Mauro MJ;Hematology Am Soc Hematol Educ Program,2006
4. Chronic myeloid leukemia. (2023). Accessed. January 13, 2024: https://emedicine.medscape.com/article/199425-overview.
5. Cancer Stat Facts. Leukemia — chronic myeloid leukemia (CML). (2023). Accessed: January 13, 2024: https://seer.cancer.gov/statfacts/html/cmyl.html.